Core Viewpoint - The National Medical Products Administration (NMPA) has issued an opinion aimed at deepening the reform of cosmetics regulation and promoting high-quality development in the industry over the next 5 to 10 years, with 24 reform measures proposed to enhance safety and innovation in the cosmetics sector [1][2]. Group 1: Industry Overview - China is the world's largest cosmetics market, with over 20,000 cosmetics companies and 4.6 million registered special cosmetics varieties, alongside 2.29 million filed ordinary cosmetics varieties [1]. - The domestic cosmetics market is projected to exceed 1 trillion yuan in transaction value by 2024, with domestic brands holding a market share of 55.2% [1]. Group 2: Reform Measures - The opinion outlines 24 reform measures focusing on five areas: encouraging innovation, optimizing registration and filing management, strengthening risk prevention across the supply chain, enhancing smart regulatory capabilities, and aligning regulations with international standards [2]. - Specific measures include supporting raw material innovation, establishing a classification management and technical evaluation system for new raw materials, and creating a collaborative mechanism for research and review to improve the quality of research and application [2]. Group 3: Regulatory Changes - The NMPA will set up a special review channel for new efficacy cosmetics, implementing immediate review processes and establishing a pre-consultation mechanism for registration applications, thereby adapting to new consumer demands and industry trends [3]. - The opinion allows international new cosmetics that meet certain criteria to bypass the requirement of submitting sales license proof, facilitating faster market entry and enhancing consumer access to global beauty products [3]. Group 4: Registration and Filing Reform - The opinion proposes specific measures to optimize registration and filing management, such as simplifying application materials and allowing similar products from the same brand to share safety and efficacy evaluation data [4]. - The review mechanism will be optimized, with a collaborative review system between national and provincial levels, and reduced review times for high-risk and low-risk registration changes [4]. - The NMPA plans to implement these reforms within three years, aiming to enhance the production quality management system in the cosmetics industry [4].

Core Viewpoint - The article discusses the release of the "Opinions on Deepening Cosmetic Regulation Reform to Promote High-Quality Development" by the National Medical Products Administration, which outlines 24 reform opinions and 48 specific measures aimed at modernizing the regulatory system and upgrading the cosmetic industry in China by 2035 [4][5][21]. Group 1: Reform Objectives - The document aims to achieve a regulatory system that meets international advanced standards by 2035, enhancing the innovation capacity and global competitiveness of the cosmetic industry [4][21]. - It sets a two-step goal: by 2030, to improve regulatory frameworks and risk management systems, and by 2035, to fully modernize the regulatory approach [21][22]. Group 2: Key Reform Areas - Encouraging innovation by establishing fast-track review channels for new efficacy cosmetics and supporting the development of products for the elderly [6][13]. - Optimizing registration and filing management to enhance service efficiency, including simplifying documentation and establishing a collaborative review mechanism [7][25]. - Strengthening production and operational supervision to build a risk prevention system, including differentiated regulatory measures based on risk levels [8][27]. - Solidifying technical support to modernize regulatory capabilities, including enhancing the review and inspection workforce and promoting the use of artificial intelligence [10][31]. - Promoting international alignment to enhance global competitiveness, including reducing animal testing requirements and improving the adaptability of raw materials [11][30]. Group 3: Highlights of the Reform - Establishing a fast-track review mechanism for new efficacy products to stimulate research and development [13][16]. - Positioning China as a global launch site for new products by removing barriers to international product launches [14][16]. - Focusing on the "silver economy" by encouraging the development of cosmetics tailored for the elderly [15][16]. - Implementing electronic label trials to enhance consumer experience and support sustainable development [15][16]. - Improving the quality management system within three years to address industry weaknesses [18][24]. Group 4: Industry Context - The Chinese cosmetic market is projected to exceed 1 trillion yuan by 2024, becoming the largest global market, with over 2.3 million product registrations as of October 2025 [18][24]. - Despite rapid growth, the industry faces challenges such as insufficient innovation capabilities and a lagging quality management system [18][19][24]. - The article emphasizes the need for a modernized regulatory framework to address these challenges and enhance the industry's competitiveness on a global scale [20][22].

Core Viewpoint - The National Medical Products Administration (NMPA) has released an opinion aimed at reforming cosmetics regulation to promote high-quality industry development, with goals set for 2030 and 2035 to enhance regulatory frameworks, innovation, and safety standards [1] Group 1: Industry Innovation Development - The opinion emphasizes support for innovation in cosmetic raw materials, which are crucial for product safety and efficacy. The NMPA has introduced measures to stimulate raw material research and registration [2] - It proposes optimizing the classification and technical evaluation system for new raw materials, establishing naming rules that align with national conditions and international standards, and enhancing standard-setting for frequently used and high-risk raw materials [2] - A collaborative mechanism for research and review will be constructed to provide comprehensive support for new raw materials, improving the quality of research and application [2] Group 2: New Efficacy Cosmetics Registration - The opinion introduces a specialized review channel for new efficacy cosmetics, allowing for immediate review upon submission and establishing a pre-consultation mechanism to guide enterprises [3] - It aims to simplify product management requirements by adjusting classification rules, thereby supporting industry innovation and meeting new consumer demands [3] Group 3: Encouragement of New Product Launches - The opinion encourages the launch of new cosmetics in China, allowing international products to bypass certain documentation requirements, thus facilitating faster market entry [4] - This initiative aims to enhance consumer access to the latest global beauty products and stimulate domestic consumption, shifting from basic needs to quality upgrades [4] Group 4: Registration and Filing Reform - As of October 2025, over 20,000 companies are registered for cosmetics in China, with a market transaction value exceeding 1 trillion yuan in 2024, making it the largest consumer market globally [5] - The opinion outlines three reform measures focused on modernizing regulatory capabilities and improving review efficiency to create a scientific and efficient governance system for cosmetics [5] Group 5: Specific Measures for Registration and Filing - The opinion proposes specific measures to optimize registration and filing management, such as simplifying application materials and allowing similar products to share safety and efficacy evaluation data [6] - It introduces a collaborative review mechanism between national and provincial levels for special cosmetics, reduces review times for high-risk changes, and allows companies to maintain product information independently for non-safety-related changes [6]

Core Viewpoint - The article discusses the recent issuance of the "Opinions on Deepening Cosmetic Regulation Reform to Promote High-Quality Development" by the National Medical Products Administration, aimed at transforming China from a "cosmetic manufacturing giant" to a "cosmetic powerhouse" through 24 reform opinions and 48 specific measures [3][4]. Group 1: Regulatory Reforms - The "Opinions" introduce a dedicated review channel for "new efficacy cosmetics," implementing an "immediate report and review" system, which significantly reduces the time for technical reviews from three months to a more efficient process [5]. - The document encourages the launch of new cosmetic products in China, aiming to make it a global first-launch hub, thus removing barriers for international products to enter the Chinese market [5][6]. - It promotes the development of cosmetics tailored for the aging population, recognizing the "silver economy" as a new market opportunity [6]. Group 2: Industry Support Measures - The "Opinions" propose measures to reduce burdens on companies, such as allowing similar formula products to share technical data and streamlining the review process for special cosmetics [6][7]. - It emphasizes the reduction of animal testing requirements, prioritizing the development of alternative testing methods [6][7]. - The introduction of electronic labels is mandated, allowing consumers to access comprehensive product information through QR codes, enhancing user experience and operational efficiency for companies [6][7]. Group 3: Innovation and Customization - The document encourages personalized services in cosmetics, allowing companies to offer on-site mixing and repackaging of registered products based on consumer preferences [7]. - Overall, the 24 measures aim to foster innovation and development in the industry, benefiting companies by easing regulatory constraints [7].

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of opinions aimed at deepening cosmetic regulation reform and promoting high-quality development in the industry, focusing on safety, innovation, and market expansion [1][2]. Group 1: Regulatory Reforms - The NMPA will establish a special review channel for new efficacy cosmetics, implementing an "immediate report and review" system to streamline the approval process and support innovative research [2][3]. - The opinions include 24 reform suggestions and 48 specific measures to enhance category innovation, regulatory optimization, and industry empowerment [1]. Group 2: Market Expansion - The new policies aim to make China a global launch hub for new cosmetic products by allowing international brands to bypass certain licensing requirements, thus accelerating their entry into the Chinese market [3]. - The domestic cosmetic market is projected to exceed 1 trillion yuan in transaction volume by 2024, with domestic brands holding a market share of 55.2% [1]. Group 3: Silver Economy - The opinions emphasize the development of cosmetics tailored for the elderly, encouraging companies to focus on research related to skin aging and to expedite the registration and listing processes for these products [3][4]. - The potential of the silver economy is recognized as a significant growth area, with specialized products for older consumers becoming a key innovation track [4]. Group 4: Digital Transformation - The NMPA plans to implement electronic labeling for cosmetics, enhancing information accessibility and consumer understanding through digital formats [4][5]. - The regulatory framework will be optimized to reduce the burden on companies, focusing resources on high-risk areas while ensuring a non-intrusive regulatory environment [5].

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of opinions aimed at reforming the cosmetics regulatory framework to promote high-quality development in the industry, which is expected to invigorate the trillion-yuan cosmetics market in China [1] Group 1: Regulatory Reforms - The opinions propose a comprehensive reform of the cosmetics regulatory system over the next 5 to 10 years, including 24 reform suggestions and 48 specific measures to enhance product innovation, regulatory optimization, and industry empowerment [1] - A new review channel for innovative efficacy cosmetics will be established, allowing for immediate review upon submission, which aims to reduce the high trial-and-error costs previously faced by companies [3] Group 2: Market Expansion - The introduction of a policy allowing international cosmetics to launch in China without the need for prior sales license documentation is expected to accelerate the entry of new products into the market, thereby enhancing consumer access to global innovations [4] - The domestic cosmetics market is projected to exceed 1 trillion yuan in transaction value by 2024, with domestic brands holding a market share of 55.2% [1] Group 3: Targeting Demographic Needs - The opinions emphasize the importance of developing cosmetics tailored for the aging population, encouraging companies to focus on research related to skin aging and to expedite the registration and market entry of products designed for older consumers [5][6] - The growing demand from the elderly demographic is recognized as a significant opportunity for innovation within the cosmetics industry [6] Group 4: Digital Transformation - The NMPA plans to implement electronic labeling for cosmetics, enhancing the clarity and accessibility of product information for consumers, which aligns with the digital transformation of regulatory practices [7] - The initiative aims to streamline the registration process and reduce the burden on companies by optimizing the requirements for registration and documentation [7]

Core Viewpoint - The National Medical Products Administration (NMPA) has issued guidelines to enhance the regulation of cosmetics, focusing on improving online business oversight and ensuring high-quality industry development [1] Group 1: Regulatory Enhancements - Strengthening online business regulation through a comprehensive "internet management" mechanism [1] - Continuous optimization of the national cosmetics online business monitoring platform to enhance risk identification and monitoring efficiency [1] - Emphasizing the responsibility of e-commerce platforms in managing operators within their ecosystems [1] Group 2: Risk Management - Ongoing collaboration in regulatory efforts and risk governance to address safety risks in cosmetics [1] - Increased monitoring of typical illegal activities such as unregistered products, illegal additives, and self-formulated products [1] - Aiming to elevate the quality and safety standards of cosmetics sold online [1]

Core Viewpoint - The National Medical Products Administration (NMPA) has released an opinion aimed at deepening cosmetic regulation reform to promote high-quality development in the industry, proposing 24 reform measures across five key areas [1] Group 1: Reform Measures - The opinion emphasizes encouraging innovation within the cosmetic industry [1] - It aims to optimize registration and filing management processes [1] - The document highlights the importance of strengthening risk prevention and control throughout the entire supply chain [1] - It seeks to enhance smart regulatory capabilities [1] - The opinion promotes alignment of regulations with international standards [1] Group 2: Future Goals - By 2030, the regulatory legal system for cosmetics is expected to be more complete, with a more robust standard system and stronger technical support [1] - The industry is anticipated to exhibit increased innovation vitality and comprehensive risk prevention capabilities, leading to significant improvements in quality and safety levels [1] - By 2035, the cosmetic quality and safety regulatory system is projected to reach international advanced levels, with enhanced innovation and global competitiveness [1] - The goal is to achieve modernization of regulatory practices within the industry [1]

Core Viewpoint - The National Medical Products Administration of China has issued a document aimed at transforming the country from a "cosmetics manufacturing giant" to a "cosmetics powerhouse," proposing 24 reform opinions and 48 specific measures to enhance the quality and safety of the cosmetics industry [1][2]. Group 1: Regulatory Reforms - The document introduces a dedicated review pathway for "new efficacy cosmetics," allowing for "immediate reporting and review," which significantly reduces the time required for technical reviews and registration [2]. - It encourages the launch of new cosmetics in China, aiming to make the country a global hub for new product launches, thus eliminating the need for proof of prior sales in the production country [2]. - The document promotes the development of cosmetics tailored for the aging population, recognizing the "silver economy" as a new market opportunity [3]. Group 2: Industry Efficiency - A series of measures are introduced to reduce burdens on companies, such as allowing similar products to share technical data and streamlining the review process for special cosmetics [3][4]. - The document emphasizes the reduction of animal testing requirements, prioritizing the development of alternative testing methods [3]. - It mandates the implementation of electronic labels for cosmetics, enhancing consumer access to product information and improving operational efficiency for companies [3]. Group 3: Customization and Innovation - The document encourages personalized services in cosmetics, allowing for on-site adjustments and repackaging based on consumer needs, aligning with the trend of personalized consumption [4]. - Overall, the 24 reform measures aim to liberate the industry from constraints, fostering innovation and development within the cosmetics sector [5].

Core Viewpoint - The National Medical Products Administration (NMPA) has released a set of reform measures aimed at enhancing the regulation of cosmetics in China, focusing on promoting high-quality development in the industry [1] Group 1: Reform Measures - The reforms consist of 24 measures across five key areas: encouraging innovation, optimizing registration and filing management, strengthening risk prevention across the entire supply chain, enhancing smart regulatory capabilities, and aligning regulations with international standards [1] - The goal is to solidify the quality and safety baseline of cosmetics, cultivate new productive forces, and drive high-quality development in the cosmetics industry [1] Group 2: Future Goals - By 2030, the regulatory legal framework for cosmetics is expected to be more complete, with a more robust standard system, stronger technical support, increased innovation vitality, enhanced risk prevention capabilities, and significantly improved quality and safety levels [1] - By 2035, the cosmetics quality and safety regulatory system aims to reach international advanced levels, with the industry exhibiting greater innovation and global competitiveness, and achieving modernization in regulation [1]